Fe Pharmaceuticals

Fe Pharmaceuticals is developing DIBI, a non-toxic, iron-binding copolymer, as a potent (<uM MIC), broad-spectrum, antimicrobial agent active against bacterial and fungal infections, including drug resistant organisms. Source (opens in a new tab)

Website

https://fepharm.com/

Headquarters

US